FG
MDT icon

Fairman Group’s Medtronic MDT Stock Holding History

Fairman Group’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$790 Hold
10
– – ﹤0.01% 306
2026
Q1 		$874 Hold
10
– – ﹤0.01% 296
2025
Q4 		$975 Sell
10
-10
-50% -$971 ﹤0.01% 304
2025
Q3 		$1.92K Hold
20
– – ﹤0.01% 232
2025
Q2 		$1.76K Hold
20
– – ﹤0.01% 211
2025
Q1 		$1.61K Hold
20
– – ﹤0.01% 208
2024
Q4 		$1.61K Sell
20
-16
-44% -$1.39K ﹤0.01% 235
2024
Q3 		$3.27K Hold
36
– – ﹤0.01% 230
2024
Q2 		$2.86K Hold
36
– – ﹤0.01% 234
2024
Q1 		$3.16K Hold
36
– – ﹤0.01% 221
2023
Q4 		$2.99K Buy
+36
New +$2.74K ﹤0.01% 223

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Fairman Group's MDT Position: Q2 2026 in Review

Fairman Group held its Medtronic (MDT) position steady in Q2 2026 at 10 shares worth $790. The position accounts for ﹤0.01% of the portfolio, ranked #306.

Fairman Group first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.27K in Q3 2024. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Fairman Group held 10 shares of Medtronic worth $790 as of Q2 2026.
  • Fairman Group left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up ﹤0.01% of Fairman Group's portfolio in Q2 2026, its #306 holding.
  • Fairman Group first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Fairman Group's Medtronic position peaked at $3.27K in Q3 2024.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Fairman Group's 13F filing for Q2 2026, filed 4 Aug 2026.